Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly GMPs Clear One Milestone; Cymbalta Launch Now Planned For Summer

Nov 03 2003

• By The Pink Sheet

Related Content

Lilly Cialis Using Alternate Manufacturing Facilities For 2nd Half 2003 Launch

Jul 22 2002

Lilly Revisits Priorities: GMPs Awarded Same Status As R&D, Marketing

Jul 07 2003

Lilly Cymbalta Approval Timeline In Doubt After Delay In Second NDA

Sep 08 2003

J&J Risperdal Consta Priced Comparable To Zyprexa; Clears FDA Oct. 29

Nov 03 2003

Duloxetine’s Dual Names: Lilly Wants Yentreve As Incontinence Brand

Oct 27 2003

Zyprexa IM Manufacturing Issues To Be Discussed By FDA, Lilly March 15

Mar 12 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window